Literature DB >> 21134964

Native properdin binds to Chlamydia pneumoniae and promotes complement activation.

Claudio Cortes1, V P Ferreira, Michael K Pangburn.   

Abstract

Activation of complement represents one means of natural resistance to infection from a wide variety of potential pathogens. Recently, properdin, a positive regulator of the alternative pathway of complement, has been shown to bind to surfaces and promote complement activation. Here we studied whether properdin-mediated complement activation occurs on the surface of Chlamydia pneumoniae, an obligate intracellular Gram-negative bacterium that causes 10 to 20% of community-acquired pneumonia. We have determined for the first time that the physiological P₂, P₃, and P₄ forms of human properdin bind to the surface of Chlamydia pneumoniae directly. The binding of these physiological forms accelerates complement activation on the Chlamydia pneumoniae surface, as measured by C3b and C9 deposition. Finally, properdin-depleted serum could not control Chlamydia pneumoniae infection of HEp-2 cells compared with normal human serum. However, after addition of native properdin, the properdin-depleted serum recovered the ability to control the infection. Altogether, our data suggest that properdin is a pattern recognition molecule that plays a role in resistance to Chlamydia infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21134964      PMCID: PMC3028849          DOI: 10.1128/IAI.00980-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

Review 1.  Properdin deficiency: molecular basis and disease association.

Authors:  C A Fijen; R van den Bogaard; M Schipper; M Mannens; M Schlesinger; F G Nordin; J Dankert; M R Daha; A G Sjöholm; L Truedsson; E J Kuijper
Journal:  Mol Immunol       Date:  1999 Sep-Oct       Impact factor: 4.407

2.  Inhibition of complement alternative pathway function with anti-properdin monoclonal antibodies.

Authors:  R Gupta-Bansal; J B Parent; K R Brunden
Journal:  Mol Immunol       Date:  2000-04       Impact factor: 4.407

3.  Multiple Chlamydia pneumoniae antigens prime CD8+ Tc1 responses that inhibit intracellular growth of this vacuolar pathogen.

Authors:  Benjamin Wizel; Barry C Starcher; Buka Samten; Zissis Chroneos; Peter F Barnes; John Dzuris; Yuichiro Higashimoto; Ettore Appella; Alessandro Sette
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

Review 4.  The chlamydial inclusion: escape from the endocytic pathway.

Authors:  Kenneth A Fields; Ted Hackstadt
Journal:  Annu Rev Cell Dev Biol       Date:  2002-04-02       Impact factor: 13.827

Review 5.  Chlamydia pneumoniae, asthma, and COPD: what is the evidence?

Authors:  D L Hahn
Journal:  Ann Allergy Asthma Immunol       Date:  1999-10       Impact factor: 6.347

6.  Complement-mediated lipopolysaccharide release and outer membrane damage in Escherichia coli J5: requirement for C9.

Authors:  A M O'Hara; A P Moran; R Würzner; A Orren
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

7.  The endothelium as physiological source of properdin: role of wall shear stress.

Authors:  Mauro Bongrazio; Axel R Pries; Andreas Zakrzewicz
Journal:  Mol Immunol       Date:  2003-01       Impact factor: 4.407

8.  Properdin deficiency associated with recurrent otitis media and pneumonia, and identification of male carrier with Klinefelter syndrome.

Authors:  Lone Schejbel; Vibeke Rosenfeldt; Hanne Marquart; Niels Henrik Valerius; Peter Garred
Journal:  Clin Immunol       Date:  2009-03-27       Impact factor: 3.969

9.  Complement activation by tubular cells is mediated by properdin binding.

Authors:  Hilde Gaarkeuken; Machiel A Siezenga; Kim Zuidwijk; Cees van Kooten; Ton J Rabelink; Mohamed R Daha; Stefan P Berger
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-27

10.  Complement gene expression in human cardiac allograft biopsies as a correlate of histologic grade of injury.

Authors:  Karen Keslar; E Rene Rodriguez; Carmela D Tan; Randall C Starling; Peter S Heeger
Journal:  Transplantation       Date:  2008-11-15       Impact factor: 4.939

View more
  32 in total

1.  Functional and structural insight into properdin control of complement alternative pathway amplification.

Authors:  Dennis V Pedersen; Lubka Roumenina; Rasmus K Jensen; Trine Af Gadeberg; Chiara Marinozzi; Capucine Picard; Tania Rybkine; Steffen Thiel; Uffe Bs Sørensen; Cordula Stover; Veronique Fremeaux-Bacchi; Gregers R Andersen
Journal:  EMBO J       Date:  2017-03-06       Impact factor: 11.598

Review 2.  Complement and Bacterial Infections: From Molecular Mechanisms to Therapeutic Applications.

Authors:  Dani A C Heesterbeek; Mathieu L Angelier; Richard A Harrison; Suzan H M Rooijakkers
Journal:  J Innate Immun       Date:  2018-08-27       Impact factor: 7.349

3.  Properdin binding to complement activating surfaces depends on initial C3b deposition.

Authors:  Morten Harboe; Christina Johnson; Stig Nymo; Karin Ekholt; Camilla Schjalm; Julie K Lindstad; Anne Pharo; Bernt Christian Hellerud; Kristina Nilsson Ekdahl; Tom Eirik Mollnes; Per H Nilsson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-09       Impact factor: 11.205

Review 4.  The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?

Authors:  Richard A Harrison
Journal:  Semin Immunopathol       Date:  2017-11-22       Impact factor: 9.623

5.  Properdin Contributes to Allergic Airway Inflammation through Local C3a Generation.

Authors:  Yuan Wang; Takashi Miwa; Blerina Ducka-Kokalari; Imre G Redai; Sayaka Sato; Damodar Gullipalli; James G Zangrilli; Angela Haczku; Wen-Chao Song
Journal:  J Immunol       Date:  2015-06-26       Impact factor: 5.422

6.  Opsonophagocytosis of Chlamydia pneumoniae by Human Monocytes and Neutrophils.

Authors:  Mads Lausen; Mathilde Selmar Pedersen; Nareen Sherzad Kader Rahman; Liv Therese Holm-Nielsen; Faduma Yahya Mohamed Farah; Gunna Christiansen; Svend Birkelund
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

7.  Analysis of complement deposition and processing on Chlamydia trachomatis.

Authors:  Mads Lausen; Mikkel Eggert Thomsen; Gunna Christiansen; Nichlas Karred; Allan Stensballe; Tue Bjerg Bennike; Svend Birkelund
Journal:  Med Microbiol Immunol       Date:  2020-11-18       Impact factor: 3.402

8.  Identification of a novel mode of complement activation on stimulated platelets mediated by properdin and C3(H2O).

Authors:  Gurpanna Saggu; Claudio Cortes; Heather N Emch; Galia Ramirez; Randall G Worth; Viviana P Ferreira
Journal:  J Immunol       Date:  2013-05-15       Impact factor: 5.422

Review 9.  Properdin in complement activation and tissue injury.

Authors:  Allison M Lesher; Bo Nilsson; Wen-Chao Song
Journal:  Mol Immunol       Date:  2013-06-29       Impact factor: 4.407

10.  The complement C3a receptor is critical in defense against Chlamydia psittaci in mouse lung infection and required for antibody and optimal T cell response.

Authors:  Pavel Dutow; Beate Fehlhaber; Jenny Bode; Robert Laudeley; Claudia Rheinheimer; Silke Glage; Rick A Wetsel; Oliver Pabst; Andreas Klos
Journal:  J Infect Dis       Date:  2013-11-23       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.